SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John Metcalf who wrote (245)1/31/1997 3:51:00 AM
From: GENE DAVID HART   of 6136
 
UHHH, JOHN, I ACKNOWLEDGE GILD IS OVERVALUED AND MY PREMISE IS AGPH IS OVERVALUED. TO CLARIFY, IN THIS ERA OF BIOTECHMANIA, GILD ON AN EARNINGS YIELD BASIS IS A BETTER VALUE THAN AGPH. WHEN AGPH PRODUCES POSITIVE EARNINGS, THE EARNINGS YIELD VALUATION CHANGES. THANKS FOR THE INFO ON MARKET CAP VALUATION. GDH
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News